Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Garrett Nichols Insider Profile
4 Followers
Garrett Nichols, CMO at Chimerix, holds 100.55K shares in Candel Therapeutics (Ticker: CADL), holds 260.07K shares in Chimerix (Ticker: CMRX). Most recently, Garrett Nichols Sold ― shares of Candel Therapeutics on Dec 03, 2024 for an estimated value of 63.40K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-150.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Garrett Nichols
Garrett Nichols's Trading History
Chimerix
Feb 11, 2020
CMO
Informative Sell
19.13K
$777.60K
Candel Therapeutics
Dec 03, 2024
CMO
Informative Sell
63.40K
$879.79K
List of latest transactions for each holding click on a transaction to see Garrett Nichols's performance on stock
You May Also Like
Garrett Nichols insider profile FAQ
What is the percentage of profitable transactions made by Garrett Nichols?
The percentage of profitable transactions made by Garrett Nichols is 40%.
What is the average return per transaction made by Garrett Nichols?
The average return per transaction made by Garrett Nichols is -150.60%.
What stocks does Garrett Nichols hold?
Garrett Nichols holds: CMRX, CADL stocks.
What was Garrett Nichols’s latest transaction?
Garrett Nichols latest transaction was an Informative Sell of $63.40K.
What was Garrett Nichols's most profitable transaction?
Garrett Nichols’s most profitable transaction was an Informative Sell of CADL stock on July 15, 2024. The return on the trade was 22.30%.
What is Garrett Nichols's role in Chimerix?
Garrett Nichols's role in Chimerix is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.